Celeste Rachelle Fralick

Board Director

Director

US·SEC (Form 4)

Aspira Women's Health Inc.

Total declarations

Company

▲ Purchases (2 ops.)

€2,713

▼ Sales (0 ops.)

—

Latest filing published 01 Apr 2025 for Aspira Women's Health Inc.. Read the official filing

Filing timeline

BuySale

Celeste Rachelle Fralick

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-20.5%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Celeste Rachelle Fralick: trading record in brief

Celeste Rachelle Fralick is a declared insider of Aspira Women's Health Inc. (board member), with filings sourced from SEC (Form 4). The record holds 10 filings, for trades running from 31 March 2022 to 31 March 2025.

The open-market record is one-sided, with 2 purchases worth €2,713 and not one sale. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants and 3 option exercises.

The latest filing, published on 1 April 2025, reports an option exercise in Aspira Women's Health Inc. The last purchase on record was published on 26 July 2023, which is 1,180 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.